Previously treated cases tested for RR-/MDR-TB (%) in Senegal
Senegal: Previously treated cases tested for RR-/MDR-TB was 87.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Senegal, 2007–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Senegal is 87.0%, measured in 2024.
That represents a change of up 22.5% on the previous year and down 13.0% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Senegal peaked at 100.0% in 2014 and was at its lowest, 2.7%, in 2008.
That places Senegal 92nd out of 180 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Senegal, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 3.6% | — |
| 2008 | 2.7% | -25.0% |
| 2009 | 2.8% | +3.7% |
| 2010 | 6.4% | +128.6% |
| 2011 | 8.7% | +35.9% |
| 2012 | 14.0% | +60.9% |
| 2013 | 35.0% | +150.0% |
| 2014 | 100.0% | +185.7% |
| 2015 | 100.0% | +0.0% |
| 2016 | 83.0% | -17.0% |
| 2017 | 100.0% | +20.5% |
| 2018 | 67.0% | -33.0% |
| 2019 | 100.0% | +49.3% |
| 2020 | 95.0% | -5.0% |
| 2021 | 100.0% | +5.3% |
| 2022 | 90.0% | -10.0% |
| 2023 | 71.0% | -21.1% |
| 2024 | 87.0% | +22.5% |
Senegal compared with similar countries
- Senegal's 87.0% is below the median for lower middle income countries, which is 90.0%, 97% of the median. (47 countries reporting)
- Senegal's 87.0% is below the median for Sub-Saharan Africa, which is 91.5%, 95% of the median. (46 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.0% | 2.7% | 3.6% | 3 |
| 2010s | 61.4% | 6.4% | 100.0% | 10 |
| 2020s | 88.6% | 71.0% | 100.0% | 5 |
Countries ranked near Senegal
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Senegal?
- Previously treated cases tested for rr-/mdr-tb in Senegal was 87.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Senegal?
- The highest recorded value was 100.0% in 2014.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Senegal?
- The lowest recorded value was 2.7% in 2008.
- How does Senegal rank for previously treated cases tested for rr-/mdr-tb?
- Senegal ranks 92nd out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Senegal?
- Over the last ten years it is down 13.0%. The long-run trend across the full record is volatile.
- Where does this Senegal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).